Ortin Laboratories Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Ortin Laboratories Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
31.30% Gain from 52W Low
19.2
TTM PE Ratio
Negative PE TTM
-2.2
Price to Book Ratio
Below industry Median
6.1
Dividend yield 1yr %
0
TTM PEG Ratio
0
RSI
RSI is mid-range
67.8
MFI
MFI strongly Overbought
83.7

Ortin Laboratories Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Ortin Laboratories Ltd shareholding Pattern

Promoter
1.2%
Public
98.8%
Promoter
7.4%
Public
92.6%
Promoter
7.4%
Public
92.6%
Promoter
7.4%
Public
92.6%
Promoter
21.5%
Public
78.5%
Promoter
15.7%
Public
84.3%

Ortin Laboratories Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
20.20
10Day EMA
19.40
12Day EMA
19.30
20Day EMA
18.90
26Day EMA
18.80
50Day EMA
18.80
100Day EMA
19.20
200Day EMA
19.80
5Day SMA
20.30
10Day SMA
19.10
20Day SMA
18.20
30Day SMA
18.30
50Day SMA
18.80
100Day SMA
19.40
150Day SMA
20.00
200Day SMA
19.80
Delivery & Volume
Resistance & Support
20.80
Pivot
Resistance
First Resistance
21.23
Second Resistance
21.81
Third Resistance
22.24
Support
First Support
20.22
Second support
19.79
Third Support
19.21
Relative Strength Index
67.75
Money Flow Index
83.66
MACD
0.52
MACD Signal
0.10
Average True Range
1
Average Directional Index
25.62
Rate of Change (21)
15.31
Rate of Change (125)
-4
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Bacil Pharma Ltd.
-
-
-
Beryl Drugs Ltd.
-
-
-
Span Divergent Ltd.
-
-
-
Decipher Labs Ltd.
-
-
-
Unjha Formulations Ltd.
-
-
-
Dipna Pharmachem Ltd.
-
-
-

Ortin Laboratories Ltd Company background

Founded in: 1986
Managing director: S Murali Krishna Murthy
Ortin Laboratories Limited was incorporated in October, 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. The Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations. They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India. The company is having their manufacturing unit at Medak in Andhra Pradesh, which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations.The company offer anti arthritic drugs, antibiotics, chemo therapeutics, analgesics and antipyretics, cardiac and cardio vascular drugs, anti diarroheal drugs, anti depressants, anti hypertensive, anti aids, anti tuberculosis drugs, gynaecological drugs, antibiotics, anti diabetic, antacids anti ulcer drugs, anti allergics, anticold, decongestants, antioxidents, vitamins, minerals, anti bacterial drugs, anti emetics, anti helmenthetics, nutritional supplements and protein, and appetizers. They also produce dental, ophthalmology, pediatric, diuretics, dermatology, psychiatry, and ENT drugs. The company constructed a Factory in a spacious area of 25,000 sq feet with all ultramodern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of tablets capsules syrups dry powders ointments. During the year 200304, the company started their second division of products and marketing in few states. During the year 200607, the company got listed their shares in BSE Indonext model, which provided a nationwide trading platform for the investors of the company for their effective participation. They completed the up gradation of factory premises as per Revised Schedule M and started exporting their products to Asian, African countries and Middle East countries.During the year 200910, the company acquired the certification for the registration with National Drug Authority, Uganda wherein the company has got the eligibility to export their products to Uganda.During the year 201011, Vineet Laboratories Pvt Ltd, a private limited company engaged in the manufacturing of Fine Chemicals, Custom synthesis and specialized in making bulk drug intermediates for anti retrovirals and lipid lowering agents, etc was amalgamated with the company. Also, the company was allotted 6.18 acres of land in IDA, Buchinelli, Zaheerabad, Medak Dist., AP by APIIC. The company is planning to construct USFDA and European Standard Bulk Drug manufacturing facility.In 201011, M/s. Vineet Laboratories Private Limited (VLPL) was merged with the Company through the Scheme of Amalgamation, which was made effective from October 01, 2010. In terms of the said Scheme of Amalgamation, the Equity Shareholders of VLPL were entitled 17 Equity Shares of the Company for every 10 Equity Share held in Vineet Laboratories Private Limited. Thus, 1,22,40,000 fully paidup equity shares of Rs. 10/ each of the Company were issued and allotted to the equity shareholders of Vineet Laboratories Private Limited in the same proportion as to their shareholding in Vineet Laboratories Private Limited.In 201718, the scheme of arrangement between the Company and Vineet Laboratories Limited for demerger of the API Intermediates Division of the Company as a going concern was implemented.
Read More

Ortin Laboratories Ltd FAQs

The past 1-year return of Ortin Laboratories Ltd [ORTINLAB] share was -11.7. The Ortin Laboratories Ltd [ORTINLAB] share hit a 1-year low of Rs. 16.15 and a 1-year high of Rs. 26.39.

You can easily buy Ortin Laboratories Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage